Fate Therapeutics (FATE) EBT Margin (QoQ) (2012 - 2026)
Fate Therapeutics (FATE) EBT Margin (QoQ) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Fate Therapeutics | 302.48 Mn | 302.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -899,745.00 |
| Dec 31, 2025 | 195,063.00 |
| Sep 30, 2025 | -196,670.00 |
| Jun 30, 2025 | 794,753.00 |
| Mar 31, 2025 | 1.23 Mn |
| Dec 31, 2024 | -1.61 Mn |
| Sep 30, 2024 | -361,001.00 |
| Jun 30, 2024 | 251,720.00 |
| Mar 31, 2024 | 1.65 Mn |
| Dec 31, 2023 | -1.10 Mn |
| Sep 30, 2023 | 211,250.00 |
| Jun 30, 2023 | -1.29 Mn |
| Mar 31, 2023 | 65,240.00 |
| Dec 31, 2022 | 22,988.00 |
| Sep 30, 2022 | 40,653.00 |
| Jun 30, 2022 | -95,397.00 |
| Mar 31, 2022 | 124,441.00 |
| Dec 31, 2021 | -3,293.00 |
| Sep 30, 2021 | -75,170.00 |
| Jun 30, 2021 | 20,887.00 |